May S. Lui

1.4k total citations
30 papers, 1.2k citations indexed

About

May S. Lui is a scholar working on Molecular Biology, Infectious Diseases and Cancer Research. According to data from OpenAlex, May S. Lui has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 15 papers in Infectious Diseases and 11 papers in Cancer Research. Recurrent topics in May S. Lui's work include Biochemical and Molecular Research (24 papers), HIV/AIDS drug development and treatment (15 papers) and Cancer, Hypoxia, and Metabolism (9 papers). May S. Lui is often cited by papers focused on Biochemical and Molecular Research (24 papers), HIV/AIDS drug development and treatment (15 papers) and Cancer, Hypoxia, and Metabolism (9 papers). May S. Lui collaborates with scholars based in United States, Malaysia and Japan. May S. Lui's co-authors include George Weber, Mary A. Faderan, Edith Oláh, Robert Jackson, Eiji Takeda, Yutaka Natsumeda, J. E. Denton, Diana Y. Tzeng, Yong‐Su Zhen and Theodore J. Boritzki and has published in prestigious journals such as Journal of Biological Chemistry, Applied Physics Letters and JNCI Journal of the National Cancer Institute.

In The Last Decade

May S. Lui

30 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
May S. Lui United States 22 857 339 187 177 177 30 1.2k
G. A. LePage United States 29 1.7k 1.9× 352 1.0× 418 2.2× 324 1.8× 373 2.1× 106 2.4k
Martin Sweeney United States 17 523 0.6× 156 0.5× 148 0.8× 208 1.2× 61 0.3× 29 918
Barbara A. Domin United States 20 501 0.6× 181 0.5× 209 1.1× 88 0.5× 83 0.5× 31 1.1k
Theodore J. Boritzki United States 19 676 0.8× 160 0.5× 72 0.4× 244 1.4× 53 0.3× 32 1.0k
David R. Borcherding United States 19 600 0.7× 216 0.6× 192 1.0× 680 3.8× 223 1.3× 29 1.5k
Linda L. Wotring United States 22 632 0.7× 233 0.7× 223 1.2× 684 3.9× 114 0.6× 69 1.5k
Minkui Luo United States 29 2.2k 2.5× 140 0.4× 119 0.6× 296 1.7× 59 0.3× 58 2.5k
Roger Bone United States 21 934 1.1× 115 0.3× 43 0.2× 401 2.3× 32 0.2× 33 1.6k
Krystyna Lesiak United States 23 865 1.0× 315 0.9× 179 1.0× 304 1.7× 71 0.4× 67 1.3k
G L Neil United States 19 548 0.6× 98 0.3× 76 0.4× 190 1.1× 28 0.2× 42 867

Countries citing papers authored by May S. Lui

Since Specialization
Citations

This map shows the geographic impact of May S. Lui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by May S. Lui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites May S. Lui more than expected).

Fields of papers citing papers by May S. Lui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by May S. Lui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by May S. Lui. The network helps show where May S. Lui may publish in the future.

Co-authorship network of co-authors of May S. Lui

This figure shows the co-authorship network connecting the top 25 collaborators of May S. Lui. A scholar is included among the top collaborators of May S. Lui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with May S. Lui. May S. Lui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lui, May S., et al.. (1990). Oncolytic activity and mechanism of action of a novell-cystine derivative,l-cystine, ethyl ester,S-(N-methylcarbamate) monohydrochloride. Cancer Chemotherapy and Pharmacology. 26(2). 88–92. 11 indexed citations
2.
Mayer, Doris, Yutaka Natsumeda, Tadashi Ikegami, et al.. (1990). Expression of key enzymes of purine and pyrimidine metabolism in a hepatocyte-derived cell line at different phases of the growth cycle. Journal of Cancer Research and Clinical Oncology. 116(3). 251–258. 16 indexed citations
3.
Kohmoto, Shigeo, Oliver J. McConnell, Amy E. Wright, et al.. (1987). Puupehenone, A Cytotoxic Metabolite from a Deep Water Marine Sponge, Stronglyophora hartmani. Journal of Natural Products. 50(2). 336–336. 47 indexed citations
4.
Wright, Amy E., et al.. (1987). Duryne, a new cytotoxic agent from the marine sponge Cribrochalinadura. Tetrahedron Letters. 28(13). 1377–1380. 38 indexed citations
5.
Jayaram, Hiremagalur N., Konrad Pillwein, May S. Lui, Mary A. Faderan, & George Weber. (1986). Mechanism of resistance to tiazofurin in hepatoma 3924A. Biochemical Pharmacology. 35(4). 587–593. 26 indexed citations
6.
Natsumeda, Yutaka, May S. Lui, Mary A. Faderan, et al.. (1985). Purine enzymology of human colon carcinomas.. PubMed. 45(6). 2556–9. 30 indexed citations
7.
Weber, George, May S. Lui, Hiremagalur N. Jayaram, et al.. (1985). Regulation of purine and pyrimidine metabolism by insulin and by resistance to tiazofurin. Advances in Enzyme Regulation. 23. 81–99. 21 indexed citations
8.
Lui, May S., et al.. (1985). Inactivation by acivicin of rat brain CTP and GMP synthetases and depression of CTP and GTP concentrations. Advances in Enzyme Regulation. 24. 225–232. 10 indexed citations
9.
Weber, George, Yutaka Natsumeda, May S. Lui, et al.. (1984). Control of enzymic programs and nucleotide pattern in cancer cells by acivicin and tiazofurin. Advances in Enzyme Regulation. 22. 69–93. 35 indexed citations
10.
Lui, May S., Mary A. Faderan, J. J. Liepnieks, et al.. (1984). Modulation of IMP dehydrogenase activity and guanylate metabolism by tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide).. Journal of Biological Chemistry. 259(8). 5078–5082. 107 indexed citations
11.
Liepnieks, Juris J., et al.. (1984). Tiazofurin-induced selective depression of NAD content in hepatoma 3924A. Biochemical and Biophysical Research Communications. 122(1). 345–349. 10 indexed citations
12.
Weber, George, May S. Lui, Yutaka Natsumeda, & Mary A. Faderan. (1983). Salvage capacity of hepatoma 3924A and action of dipyridamole. Advances in Enzyme Regulation. 21. 53–69. 39 indexed citations
13.
Denton, J. E., May S. Lui, Takashi Aoki, et al.. (1982). Enzymology of pyrimidine and carbohydrate metabolism in human colon carcinomas.. PubMed. 42(3). 1176–83. 60 indexed citations
14.
Lui, May S., Harutoshi Kizaki, & George Weber. (1982). Biochemical pharmacology of acivicin in rat hepatoma cells. Biochemical Pharmacology. 31(21). 3469–3473. 32 indexed citations
15.
Lui, May S., et al.. (1982). Rat Hepatomas: Chemotherapy With Lycurim and Pyrazofurin<xref ref-type="fn" rid="fn2">2</xref><xref ref-type="fn" rid="fn3">3</xref>. JNCI Journal of the National Cancer Institute. 68(4). 665–8. 3 indexed citations
16.
Weber, George, Noémi Prajda, May S. Lui, et al.. (1982). Multi-enzyme-targeted chemotherapy by acivicin and actinomycin. Advances in Enzyme Regulation. 20. 75–96. 40 indexed citations
17.
Weber, George, et al.. (1981). Dynamics of modulation of biochemical programs in cancer cells. Advances in Enzyme Regulation. 19. 87–102. 33 indexed citations
18.
Jackson, Robert, May S. Lui, Theodore J. Boritzki, Harold P. Morris, & George Weber. (1980). Purine and pyrimidine nucleotide patterns of normal, differentiating, and regenerating liver and of hepatomas in rats.. PubMed. 40(4). 1286–91. 96 indexed citations
19.
Oláh, Edith, May S. Lui, Diana Y. Tzeng, & George Weber. (1980). Phase and cell cycle specificity of pyrazofurin action.. PubMed. 40(8 Pt 1). 2869–75. 33 indexed citations
20.
Weber, George, Edith Oláh, May S. Lui, & Diana Y. Tzeng. (1979). Biochemical programs and enzyme-pattern-targeted chemotherapy in cancer cells. PubMed. 17. 1–21. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. A. LePage Breakdown of academic impact, for papers by Martin Sweeney Breakdown of academic impact, for papers by Barbara A. Domin Breakdown of academic impact, for papers by Theodore J. Boritzki Breakdown of academic impact, for papers by David R. Borcherding Breakdown of academic impact, for papers by Linda L. Wotring Breakdown of academic impact, for papers by Minkui Luo Breakdown of academic impact, for papers by Roger Bone Breakdown of academic impact, for papers by Krystyna Lesiak Breakdown of academic impact, for papers by G L Neil
Rankless by CCL
2026